As certain VEGF genotypes may protect against VEGF signalling pathway inhibitor-induced HTN (Schneider et al, 2008), such prospective studies may also find new strategies for identifying patients at-risk for cardiovascular toxicities. Here, VEGFA is linked to hypertensive disorder.